Barnes Group Inc. is a global provider of highly engineered products, systems, and services for various industries including aerospace, transportation, and industrial manufacturing
The company operates through two primary segments: the Industrial segment, which offers precision components and industrial supplies, and the Aerospace segment, which focuses on manufacturing and supplying critical aircraft components and aftermarket services. Barnes Group is dedicated to innovation and quality, leveraging advanced technologies and materials to meet the evolving needs of its customers while maintaining a strong commitment to sustainability and operational excellence.
Novonesis delivers 8% organic sales growth with an adjusted EBITDA margin of 36.1% in 2024. For 2025, Novonesis presents an outlook of 5-8% organic sales growth with an adjusted EBITDA margin of 37-38%.
Novonesis has reached an agreement with dsm-firmenich to dissolve the Feed Enzyme Alliance and take over its sales and distribution activities, in exchange for a total cash consideration of EUR 1.5 billion. After more than 25 years of successful collaboration, a strategic repositioning at dsm-firmenich allowed this opportunity to materialize. This acquisition is aligned with Novonesis’ growth strategy and expands its presence across the animal biosolutions value chain. Financially, this transaction is accretive to revenue growth, adjusted EBITDA margin and adjusted EPS excl. amortization, with attractive revenue synergies.
Barnes Group Inc. (NYSEB) (“Barnes” or “the Company”), a global provider of highly engineered products, differentiated industrial technologies and innovative solutions, and Apollo NYSE: APONYSEAPO)
Barnes Group Inc. (NYSEB) (“Barnes” or “the Company”), a global provider of highly engineered products, differentiated industrial technologies and innovative solutions, today announced that its shareholders voted to approve the Company’s previously announced acquisition by funds managed by affiliates of Apollo Global Management, Inc. NYSE: APONYSEAPO)
Bagsværd, Denmark and Lexington, Massachusetts, US, 8 January 2025 – Novo Nordisk A/S and Valo Health, Inc. today announced they have entered into an expanded agreement to discover and develop novel treatments for obesity, type 2 diabetes, and cardiovascular disease based on Valo’s extensive human dataset and computation powered by artificial intelligence (AI).
NEW YORK, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Barnes Group Inc. (NYSEB) to funds managed by affiliates of Apollo Global Management, Inc. NYSE: APONYSEAPO)
NEW YORK, Dec. 14, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
NEW YORK, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
HEDEHUSENE, Denmark, Dec. 10, 2024 (GLOBE NEWSWIRE) -- The ROCKWOOL Board of Directors has approved a 100 MUSD-plus investment in a new production line in Mississippi for industrial insulation products. The new production line will help meet the growing demand from the process industry in the Gulf of Mexico region.
NEW YORK, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Following increasing demand in the first nine months of the 2024 financial year, Novonesis delivers 9% organic sales growth with a strong 11% organic sales growth in the third quarter. The strong performance has led Novonesis to now expect full-year organic sales growth to be at the upper end of the 7-8% range, and the adjusted EBITDA margin is confirmed to be between 35.5-36.5%.
NEW YORK, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Barnes Group reported 3Q24 sales increase of 7% to $388M, beating consensus. Aerospace sales surged 49%, backlog up 19%. To be acquired by Apollo Global for $3.6B.
Barnes Group Inc. (NYSEB), a global provider of highly engineered products, differentiated industrial technologies, and innovative solutions, today reported financial results for the third quarter of 2024.
NEW YORK, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Barnes Group Inc. (NYSEB) to funds managed by affiliates of Apollo Global Management, Inc. NYSE: APONYSEAPO)
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Barnes Group Inc. (NYSEB) to funds managed by affiliates of Apollo Global Management, Inc. for $47.50 per share in cash is fair to Barnes shareholders.
